CXA-10

DB15026InvestigationalSmall molecule

CXA-10 is under investigation in clinical trial NCT03422510 (FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)).

Chemical structure of CXA-10
Formula / weight
C18H33NO4 · 327.465 g/mol (avg)
Also known as
10-nitro-9(E)-octadec-9-enoic acid
Code names
CXA-10

Resolves to

Compound
UNII1N19AGY57YCAS875685-46-4ChEMBLCHEMBL561371ChEBI86285
Structure
InChIKeyWRADPCFZZWXOTI-BMRADRMJSA-NSMILESCCCCCCCC\C(=C/CCCCCCCC(O)=O)[N+]([O-])=O

What you can answer from here — as of April 23, 2025

7Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of CXA-10, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In